Navigation Links
Onyx Pharmaceuticals Reports Second Quarter 2011 Financial Results
Date:8/3/2011

SOUTH SAN FRANCISCO, Calif., Aug. 3, 2011 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today reported its financial results for the second quarter 2011. Onyx reported a non-GAAP net loss of $27.2 million, or $0.43 per diluted share, for the second quarter 2011 compared to a non-GAAP net income of $2.9 million, or $0.05 per diluted share, for the same period in 2010. Non-GAAP net loss excludes, among other items, adjustments to contingent consideration expense in connection with Onyx's acquisition of Proteolix Inc., or Proteolix; employee stock-based compensation expense; lease termination exit costs, non-cash imputed interest expense related to the application of Accounting Standards Codification ("ASC") 470-20 and charges associated with the restructuring of Onyx's development, collaboration, option and license agreement with S*BIO Pte Ltd., or S*BIO.

"The quarter was marked by continued progress across our product portfolio," said N. Anthony Coles, M.D., president and chief executive officer of Onyx. "Approved for the treatment of liver cancer and kidney cancer, Nexavar delivered another quarter of solid operating performance driven by strong growth in the Asia Pacific region. With five late-stage clinical trials expected to read-out by the end of 2012, Nexavar is poised to penetrate existing and new markets."  Dr. Coles continued, "Our Phase 3 confirmatory trials with carfilzomib, ASPIRE and FOCUS, are well underway.  Importantly, we are ramping up preparation for the commercialization of carfilzomib, in anticipation of a potential U.S. approval next year."

On a GAAP basis, Onyx reported a net loss of $54.5 million, or $0.86 per diluted share, for the second quarter 2011 compared to a net loss of $97.2 million, or $1.55 per diluted share, for the same period in 2010. A description of the non-GAAP calculations and reconciliation to co
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Access Pharmaceuticals Adds Blue Cross Blue Shield of Hawaii, SummaCare and AvMed to MuGard Payer List
2. Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 - What are the Revenue Prospects?
3. Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of August 2011
4. Avanir Pharmaceuticals to Present at Two Investor Conferences in August
5. Pacira Pharmaceuticals, Inc. Announces Data Presentations at the 38th Annual Meeting & Exposition of the Controlled Release Society
6. MAP Pharmaceuticals Announces FDA Acceptance for Filing of NDA for LEVADEX®
7. FDA Grants Orphan Drug Status to Merrimack Pharmaceuticals MM-398, a Nanotherapeutic Encapsulation of Irinotecan, for the Treatment of Pancreatic Cancer
8. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9
9. Anthera Pharmaceuticals Reports 2011 Second Quarter Financial Results and Operational Update
10. Questcor Pharmaceuticals to Present at the Canaccord Genuity Growth Conference on August 11, 2011
11. Cadence Pharmaceuticals Reaffirms FDA-Approved Dosing Recommendations for OFIRMEV® (acetaminophen) Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... BETHESDA, Md. , May 28, 2015 /PRNewswire-USNewswire/ ... that it will be a supporting organization of ... assurance and sterilization in 2016. Johnson ... a series of high-profile superbug infections in endoscopes. ... world health issues between 1976 and 2003 on ...
(Date:5/28/2015)... SAN DIEGO , May 28, 2015 /PRNewswire/ ... a clinical-stage biopharmaceutical company leveraging its molecular adhesion ... therapies for sickle cell disease, heart failure, and ... be resigning from the Company,s Board of Directors. ... potential conflict of interest given his role as ...
(Date:5/28/2015)... 2015 Compassion & Choices today is pleased to ... that would authorize the option of medical aid in dying ... The legislation, the ... mentally competent adults with six months or less to live ... painlessly and peacefully end an unbearable dying process. A vote ...
Breaking Medicine Technology:PDA Announces Support for the Johnson & Johnson Kilmer Conference 2Mast Therapeutics Announces Change In Board Of Directors 2Mast Therapeutics Announces Change In Board Of Directors 3Mast Therapeutics Announces Change In Board Of Directors 4California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 2California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 3
... http://www.omxgroup.com, OMX: DIAM B; ... http://www.otcqx.com, OTC: DMYDY), STOCKHOLM, ... that the Swedish Medical Products,Agency (MPA) has approved the Company,s ... Diamyd(R)., (Logo: http://www.newscom.com/cgi-bin/prnh/20080314/297194 ), "I am ...
... Asthma and Exercise-Induced ... Bronchoconstriction -, PLYMOUTH MEETING, Pa., ... development partner,MedImmune, has initiated its fourth phase 2a clinical trial of ... This clinical trial is designed to assess the,potential of MEDI-528 in ...
Cached Medicine Technology:Diamyd(R) Diabetes Vaccine Receives Approval to Start Phase III Trials in Europe 2Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma 2Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma 3Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma 4
(Date:5/28/2015)... Altima Technologies, Inc., the maker of popular NetZoom ... data center assets and audio-video devices, recently released ... , Manufacturer / Device Model, EMC VMAX, Cisco ... Middle Atlantic Products RSH Series, Nokia Siemens Networks ... MM Series, Extron Electronics SW Series, Crestron Electronics ...
(Date:5/28/2015)... 28, 2015 Workers’ compensation costs per claim ... a recent study by the Workers Compensation Research Institute ... three-year period. , The WCRI study, CompScope™ Benchmarks for ... missed seven days or more of work with those of ... 2011 Michigan claim was 4 percent lower than similar claims ...
(Date:5/28/2015)... More than 300 locations of the Richmond-based company ... the Muscular Dystrophy Association save and improve the lives ... that limit muscle strength and mobility by participating in ... 1 to June 30, sweetFrog associates will sell $1 ... send local children affected by neuromuscular diseases to a ...
(Date:5/28/2015)... 2015 Healthpointe is proud to ... offering Echocardiography Examinations to patients with cardiovascular needs. ... Qualified Medical Examiner and licensed Cardiologist, Dr. Oscar ... a non-invasive and cost-effective approach to effectively diagnosing ... or have undergone surgery. Also known as ...
(Date:5/28/2015)... Edmond, OK (PRWEB) May 28, 2015 ... pain relief lotion and products, today announced their best-selling lotion ... bottle. Real Time Pain Relief is an FDA registered OTC ... natural and herbal ingredients, such as Aloe Vera, Arnica, Capsicum, ... a low level of Menthol – only 1.25% – to ...
Breaking Medicine News(10 mins):Health News:NetZoom™ Visio® Stencil Library Updates for EMC, Cisco, and Chatsworth Products 2Health News:Michigan Workers’ Compensation Costs Lower Than Most States, Says WCRI Study 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 3Health News:Healthpointe Is Now Offering Echocardiography Examinations at the Anaheim Clinic. 2Health News:Real Time Pain Relief Introduces New Four Ounce Pump Bottle for their Popular Pain Relief Lotion 2
... Add Product Last Month Just as Study Lends Scientific ... To Claim That Cherries Ease Arthritis Pain, SPARTA, Mich., ... benefits of tart cherry juice, yet hesitate,to pay the premium ... Southern U.S. supermarkets. Old Orchard Brand,s 100%,Pure Tart Cherry juice ...
... June 5 Fort Dodge Animal Health, a,division of ... of,ProHeart(R) 6, a unique heartworm preventative, to the U.S. ... Food and Drug,Administration,s Center for Veterinary Medicine (CVM) of ... support the decision,to return this life-saving product to the ...
... INDIANAPOLIS -- How best to alleviate chronic pain, a ... perplex both patients and their doctors. , A ... the June 2008 issue of the Journal of General ... of therapies to treat pain have advantages and disadvantages, ...
... SAN ANTONIO, June 5 American College ... president, Dr.,Sheldon Rubin, today announced the Society,s intentions ... record canine heartworm disease,cases in the United States. ... survey, made possible through corporate sponsorship, will be,distributed ...
... prevalent in populations living nearer equator, study finds , , THURSDAY, ... D levels may play an important role in helping to ... , Researchers at the University of California, San Diego, ... living at or near the equator -- where there is ...
... of the Carnegie Institution,s Department of Embryology, has been ... Patricia Gruber Foundation in recognition of his contributions to ... earliest stages of reproduction." The prize, which consists ... to Spradling at the International Congress of Genetics in ...
Cached Medicine News:Health News:Reported Health Benefits of Tart Cherry Boosts Juice Distribution in Southern U.S. 2Health News:Fort Dodge Animal Health Announces Reintroduction of ProHeart 6 to the U.S. Veterinary Market 2Health News:Fort Dodge Animal Health Announces Reintroduction of ProHeart 6 to the U.S. Veterinary Market 3Health News:Fort Dodge Animal Health Announces Reintroduction of ProHeart 6 to the U.S. Veterinary Market 4Health News:Fort Dodge Animal Health Announces Reintroduction of ProHeart 6 to the U.S. Veterinary Market 5Health News:How best to treat chronic pain? The jury is still out 2Health News:American Heartworm Society Announces Heartworm Incidence Survey 2Health News:Sunlight, Vitamin D May Cut Kids' Diabetes Risk 2Health News:2008 Gruber Genetics Prize awarded to Allan Spradling of Carnegie Institution 2
Instrument for transphenoidal hypophysectomy, bayonet-shaped, dissector, sharp inner edge, left....
Papavero-caspar specula for trans-sphenoidal hypophysectomy....
... Triad Facet Screws ... a posterior tension band ... construct. Through utility of ... percutaneous placement of Triad ...
Cushing pituitary scoop, malleable, silver-plated....
Medicine Products: